Oxford University scientists develop world's most successful malaria vaccine

In a first, a team of scientists at Oxford University has developed a malaria vaccine that meets the World Health Organisation’s goal of over 75 percent efficacy. The vaccine uses Matriz-M adjuvant technology, the same technology that has played a key role in the development of the coronavirus vaccine by Novavax. According to a report published in Bloomberg, the vaccine named R21 is 77 percent effective against malaria.